{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T04:11:08Z","timestamp":1782274268006,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T00:00:00Z","timestamp":1658448000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"CNPq","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013904","name":"Swiss Bridge Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013904","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021671","name":"Instituto Nacional do C\u00e2ncer, Minist\u00e9rio da Sa\u00fade","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021671","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.htct.2022.06.008","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T23:56:33Z","timestamp":1659657393000},"page":"245-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Multiparametric flow cytometry directing the evaluation of CRLF2 rearrangements and JAK2 status in pediatric B cell precursor acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5381-9544","authenticated-orcid":false,"given":"Elda Pereira","family":"Noronha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1930-4285","authenticated-orcid":false,"given":"Priscilla Moniz Sodr\u00e9","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2547-2533","authenticated-orcid":false,"given":"Francianne Gomes","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4477-6690","authenticated-orcid":false,"given":"Caroline Barbieri","family":"Blunck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0592-8396","authenticated-orcid":false,"given":"Ricardo","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7091-2206","authenticated-orcid":false,"given":"Etel Rodrigues Pereira","family":"Gimba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1507-004X","authenticated-orcid":false,"given":"Maria S.","family":"Pombo-de-Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3616-140X","authenticated-orcid":false,"given":"Eug\u00eania","family":"Terra-Granado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9881","key":"10.1016\/j.htct.2022.06.008_bib0001","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1016\/S0140-6736(12)62187-4","article-title":"Acute lymphoblastic leukaemia","volume":"381","author":"Inaba","year":"2013","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.htct.2022.06.008_bib0002","doi-asserted-by":"crossref","first-page":"407","DOI":"10.3324\/haematol.2015.141101","article-title":"New and emerging prognostic and predictive genetic biomarkers in B-cell precursor acute lymphoblastic leukemia","volume":"101","author":"Moorman","year":"2016","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.htct.2022.06.008_bib0003","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.blre.2012.01.001","article-title":"The clinical relevance of chromosomal and genomic abnormalities in B-cell precursor acute lymphoblastic leukaemia","volume":"26","author":"Moorman","year":"2012","journal-title":"Blood Rev"},{"issue":"11","key":"10.1016\/j.htct.2022.06.008_bib0004","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa1403088","article-title":"Targetable kinase-activating lesions in Ph-like acute lymphoblastic leukemia","volume":"371","author":"Roberts","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.htct.2022.06.008_bib0005","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/MOH.0000000000000050","article-title":"Beyond Philadelphia: \u2018Ph-like\u2019 B cell precursor acute lymphoblastic leukemias - diagnostic challenges and therapeutic promises","volume":"21","author":"Izraeli","year":"2014","journal-title":"Curr Opin Hematol"},{"issue":"1","key":"10.1016\/j.htct.2022.06.008_bib0006","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1182\/bloodadvances.2019000163","article-title":"Clinical diagnostics and treatment strategies for Philadelphia chromosome\u2013like acute lymphoblastic leukemia","volume":"4","author":"Harvey","year":"2020","journal-title":"Blood Adv"},{"issue":"26","key":"10.1016\/j.htct.2022.06.008_bib0007","doi-asserted-by":"crossref","first-page":"5393","DOI":"10.1182\/blood-2009-11-256131","article-title":"Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non\u2013high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol","volume":"115","author":"Cario","year":"2010","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.htct.2022.06.008_bib0008","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0220026","article-title":"CRLF2 rearrangement in Ph-like acute lymphoblastic leukemia predicts relative glucocorticoid resistance that is overcome with MEK or Akt inhibition. Bertolini F, organizador","volume":"14","author":"Meyer","year":"2019","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.htct.2022.06.008_bib0009","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.3324\/haematol.2014.114447","article-title":"Fine tuning of surface CRLF2 expression and its associated signaling profile in childhood B-cell precursor acute lymphoblastic leukemia","volume":"100","author":"Bugarin","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.htct.2022.06.008_bib0010","series-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","first-page":"585","author":"Swerdlow","year":"2017"},{"issue":"9","key":"10.1016\/j.htct.2022.06.008_bib0011","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1038\/leu.2012.120","article-title":"EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes","volume":"26","author":"van Dongen","year":"2012","journal-title":"Leukemia"},{"issue":"9","key":"10.1016\/j.htct.2022.06.008_bib0012","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1038\/leu.2012.122","article-title":"EuroFlow standardization of flow cytometer instrument settings and immunophenotyping protocols","volume":"26","author":"Kalina","year":"2012","journal-title":"Leukemia"},{"issue":"1","key":"10.1016\/j.htct.2022.06.008_bib0013","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/cyto.b.21518","article-title":"AIEOP-BFM consensus guidelines 2016 for flow cytometric immunophenotyping of pediatric acute lymphoblastic leukemia: iBFM-flow standards for immunophenotyping of pediatric all","volume":"94","author":"Dworzak","year":"2018","journal-title":"Cytometry B Clin Cytom"},{"issue":"12","key":"10.1016\/j.htct.2022.06.008_bib0014","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1038\/sj.leu.2401592","article-title":"Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease","volume":"13","author":"van Dongen","year":"1999","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.htct.2022.06.008_bib0015","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/01.mph.0000210064.80828.3e","article-title":"Flow cytometric DNA index, G-band karyotyping, and comparative genomic hybridization in detection of high hyperdiploidy in childhood acute lymphoblastic leukemia","volume":"28","author":"Nygaard","year":"2006","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.htct.2022.06.008_bib0016","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.leukres.2015.11.018","article-title":"CRLF2 overexpression identifies an unfavourable subgroup of adult B-cell precursor acute lymphoblastic leukemia lacking recurrent genetic abnormalities","volume":"41","author":"Chiaretti","year":"2016","journal-title":"Leuk Res"},{"issue":"10","key":"10.1016\/j.htct.2022.06.008_bib0017","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1038\/leu.2012.101","article-title":"Poor prognosis for P2RY8-CRLF2 fusion but not for CRLF2 over-expression in children with intermediate risk B-cell precursor acute lymphoblastic leukemia","volume":"26","author":"Palmi","year":"2012","journal-title":"Leukemia"},{"issue":"23","key":"10.1016\/j.htct.2022.06.008_bib0018","doi-asserted-by":"crossref","first-page":"9414","DOI":"10.1073\/pnas.0811761106","article-title":"JAK mutations in high-risk childhood acute lymphoblastic leukemia","volume":"106","author":"Mullighan","year":"2009","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"10.1016\/j.htct.2022.06.008_bib0019","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/cyto.b.21833","article-title":"Applications of flow cytometric immunophenotyping in the diagnosis and posttreatment monitoring of B and T lymphoblastic leukemia\/lymphoma","volume":"96","author":"DiGiuseppe","year":"2019","journal-title":"Cytometry B Clin Cytom"},{"issue":"10","key":"10.1016\/j.htct.2022.06.008_bib0020","doi-asserted-by":"crossref","first-page":"e26539","DOI":"10.1002\/pbc.26539","article-title":"Molecular characterization of acute lymphoblastic leukemia with high CRLF2 gene expression in childhood","volume":"64","author":"Schm\u00e4h","year":"2017","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"10.1016\/j.htct.2022.06.008_bib0021","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/gcc.22439","article-title":"Characterisation of the genomic landscape of CRLF2-rearranged acute lymphoblastic leukemia","volume":"56","author":"Russell","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"10.1016\/j.htct.2022.06.008_bib0022","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/ajcp\/aqx005","article-title":"CRLF2-positive B-cell acute lymphoblastic leukemia in adult patients: a single-institution experience","volume":"147","author":"Konoplev","year":"2017","journal-title":"Am J Clin Pathol"},{"issue":"11","key":"10.1016\/j.htct.2022.06.008_bib0023","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1038\/leu.2017.93","article-title":"The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL","volume":"31","author":"Savino","year":"2017","journal-title":"Leukemia"},{"issue":"33","key":"10.1016\/j.htct.2022.06.008_bib0024","doi-asserted-by":"crossref","first-page":"22872","DOI":"10.18632\/oncotarget.25089","article-title":"SRC\/ABL inhibition disrupts CRLF2-driven signaling to induce cell death in B-cell acute lymphoblastic leukemia","volume":"9","author":"Sarno","year":"2018","journal-title":"Oncotarget"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137922000980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137922000980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:35:22Z","timestamp":1762868122000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137922000980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2531137922000980"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2022.06.008","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiparametric flow cytometry directing the evaluation of CRLF2 rearrangements and JAK2 status in pediatric B cell precursor acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2022.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}